Participants Recruited For NewYork-Presbyterian/Weill Cornell Study On Premenstrual Dysphoric Disorder

NewYork-Presbyterian Hospital/Weill Cornell Medical Center is recruiting participants for a multicenter study into a new treatment approach for premenstrual dysphoric disorder (PMDD), a severe and debilitating form of premenstrual syndrome (PMS) that affects up to 8 percent of women. The current standard practice for treating PMDD is anti-depressants taken either every day or for half of the menstrual cycle (14-16 days). [click link for full article]

More: continued here

Filed under: Women's Health / OBGYN on November 5th, 2007